Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.20    -0.20 (-0.23%)
Bid:
85.50
Ask:
88.00
Spread: 2.50 (2.924%)
Market Cap: £366.55m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Update

12 Jun 2014 07:00

RNS Number : 4014J
PZ CUSSONS PLC
12 June 2014
 



12 June 2014

PZ Cussons Plc

(the "Group")

 

Trading Update

 

PZ Cussons Plc, a leading consumer products group, today issues the following trading update for the year ended 31 May 2014.

 

Overview of financial performance and position

 

The board is pleased to announce that the performance of the Group for the year ended 31 May 2014 has been in line with management expectations with sterling profits* for the year expected to be approximately 6% higher than the previous year.

 

This result has been achieved despite a significant exchange impact of circa £12m from the translation and transactional effect of weakening currencies. Excluding this impact, profits* would have been 17% higher than the previous year.

 

The financial position of the Group remains strong with good cash generation and only a small net debt position at the year end.

 

Trading Update

 

Europe

 

In the UK washing and bathing division, Imperial Leather, Carex and Original Source have performed well driven by a significant renovation and innovation programme. The entire Imperial Leather range is being relaunched over the coming months with exciting new products, imagery and fragrances. Product portfolios have been optimised both for the big four supermarkets as well as further increasing distribution in other channels. The Cussons Mum & Me range is growing well together with new products under the Little Explorers sub-brand.

 

In the beauty division, consumer demand for St Tropez has been boosted by Kate Moss as brand ambassador. The Sanctuary, Charles Worthington and Fudge brands have performed well in the UK and have also now secured new overseas distribution.

 

In Poland, following the sale of the homecare brands in February for £46.6m in cash, focus is now on investing in and growing the personal care brands of Luksja, Original Source and Carex.

 

Performance in Greece has continued to show some improvement as the economy begins to stabilise.

 

Asia

 

Whilst profitability in Australia has been affected by the weaker Australian dollar, the core brands of Morning Fresh and Radiant have performed well. Rafferty's Garden has seen a number of new product launches and the international expansion will begin to be executed before the end of the calendar year.

 

Continued positive momentum in Indonesia has delivered another year of revenue growth although a weaker rupiah has impacted profits. Growth has been achieved across both the babycare and non-babycare portfolios as well as continued progress being made with distribution in other South East Asian territories.

 

Overall trading in the smaller territories of Thailand and the Middle East has been broadly in line with expectations.

 

Africa

 

In Nigeria, unrest in the North of the country has continued with increased levels of disruption over recent months. Economically, interest rates have been maintained at a high level reducing levels of liquidity in the trade. The naira has remained stable versus the US$, despite coming under pressure ahead of a change in the central bank governor.

 

In personal care and home care, whilst commodity products have had to trade in an extremely competitive environment, growth has been achieved in the value add portfolio driven by a significant brand renovation programme. Good growth has been achieved in the electricals business as well as in Nutricima, the nutritional beverage JV with Glanbia.

 

The palm oil joint venture with Wilmar has performed very well with the refinery already operating towards capacity and ahead of expectations. Good growth has been achieved in the consumer brands of Mamador and Devon Kings with the balance of output sold business to business.

 

Profitability in Ghana continues to be impacted by further weakening in the cedi. Kenya has performed well and in line with expectations.

 

Outlook

 

Whilst trading conditions in most markets remain challenging, the Group remains focussed on a dynamic and fast brand renovation and innovation programme, an ongoing cost reduction programme and successful delivery of new areas of growth such as Rafferty's Garden and the Wilmar joint venture.

 

These initiatives will help to offset the continuing macro challenges and the reduction in profits from Poland as a result of the homecare sale.

 

The Group's balance sheet remains strong and well placed to pursue new areas of growth.

 

Preliminary results

 

Preliminary results for the year ended 31 May 2014 will be announced on Tuesday 29 July 2014.

 

An analysts' presentation will be given at 9:30am on that day. This will be held at the new offices of Instinctif Partners, 65 Gresham Street, London, EC2V 7NQ. Dial in details will be available immediately following the Preliminary results announcement.

 

*profit before tax and exceptional items

- ENDS -

 

For further information contact:

 

PZ Cussons Plc Tel: 0161 435 1027

Brandon Leigh - Chief Financial Officer

 

Instinctif Tel: 020 7457 2020

Toby Bates / Tim Linacre

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGURGQUPCGCG
Date   Source Headline
29th Jun 202311:06 amRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSTrading Statement
21st Jun 20239:59 amRNSDirector/PDMR Shareholding
16th Jun 20237:00 amRNSDirectorate Change
19th May 20239:27 amRNSDirector/PDMR Shareholding
21st Apr 20239:00 amRNSIntention to Conduct Audit Tender
19th Apr 202310:01 amRNSDirector/PDMR Shareholding
13th Apr 20233:18 pmRNSHolding(s) in Company
13th Apr 20237:00 amRNSQ3 Trading Update
12th Apr 20232:18 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSDirectorate Change
21st Mar 20239:30 amRNSDirector/PDMR Shareholding
17th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20239:31 amRNSDirector/PDMR Shareholding
8th Feb 20237:00 amRNS2023 Interim Results
19th Jan 20234:20 pmRNSDirector/PDMR Shareholding
20th Dec 20222:40 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:55 pmRNSDirector/PDMR Shareholding
24th Nov 20223:24 pmRNSResult of AGM
24th Nov 20227:00 amRNSDirectorate Change
21st Nov 20223:21 pmRNSDirector/PDMR Shareholding
14th Nov 20227:00 amRNSNew Credit Facility Linked to B Corp Ambitions
18th Oct 20223:52 pmRNSDirector/PDMR Shareholding
14th Oct 20227:00 amRNSPublication of Annual Report and Notice of AGM
27th Sep 202210:52 amRNSDirector/PDMR Shareholding
23rd Sep 20223:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNS2022 Full Year Results
21st Sep 202210:06 amRNSDirector Declaration
2nd Sep 202210:29 amRNSHolding(s) in Company
19th Aug 202210:05 amRNSDirector/PDMR Shareholding
29th Jul 20229:46 amRNSDirector/PDMR Shareholding
20th Jul 20223:21 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update
21st Jun 20224:10 pmRNSDirector/PDMR Shareholding
20th May 202210:30 amRNSFurther re 2021 AGM voting results
19th May 20225:45 pmRNSDirector/PDMR Shareholding
21st Apr 202210:30 amRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSTrading Statement
1st Apr 20229:00 amRNSDirector/PDMR Shareholding
25th Mar 202210:00 amRNSDirector/PDMR Shareholding
23rd Mar 20229:00 amRNSDirector/PDMR Shareholding
21st Mar 202210:15 amRNSDirector/PDMR Shareholding
21st Mar 20227:00 amRNSAcquisition of Childs Farm
21st Feb 202211:00 amRNSDirector/PDMR Shareholding
11th Feb 20229:25 amRNSDirector/PDMR Shareholding
11th Feb 20229:15 amRNSBoard update
9th Feb 20227:00 amRNSHalf-year Report
19th Jan 202210:10 amRNSDirector/PDMR Shareholding
20th Dec 20214:35 pmRNSDirector/PDMR Shareholding
9th Dec 20219:38 amRNSNotice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.